Circulating microparticle concentrations across acute and chronic cardiovascular disease conditions
AuthorLanders-Ramos, Rian Q
Addison, Odessa A
Katzel, Leslie I
Blumenthal, Jacob B
Hagberg, James M
Prior, Steven J
MetadataShow full item record
AbstractConcentrations of different circulating microparticles (MPs) may have clinical and physiological relevance to cardiovascular disease pathologies. PURPOSE: To quantify plasma concentrations of CD31+/CD42b-, CD62E+, and CD34+ MPs across healthy individuals and those with coronary artery disease (CAD) or acute cardiovascular events (non-ST elevation myocardial infarction (NSTEMI)). Fasted blood was obtained from CAD patients (n = 10), NSTEMI patients (n = 13), and healthy older men (n = 15) 60-75 years old. METHODS: CD31+/CD42b-, CD62E+, and CD34+ MPs were isolated from plasma and quantified using flow cytometry. Relationships between MP subtypes, fasting blood lipids, blood glucose, blood pressure, body mass index, and total number of medications were assessed. RESULTS: Concentrations of CD31+/CD42b- MPs were significantly lower in CAD and NSTEMI subjects compared with healthy individuals (p = .02 and .003, respectively). No differences between groups were found for CD62E+ or CD34+ MPs (p > .05 for both). Surprisingly, among all variables assessed, only CD62E+ MP concentrations were positively correlated with triglyceride levels (p = .012) and inversely correlated with SBP (p = .03). CONCLUSIONS: Our findings provide support for the use of different MP subtypes, specifically CD31+/CD42b- MPs, as a potential biomarker of cardiovascular disease. Importantly, results from this study should be looked at in adjunct to previous MP work in CVD conditions as a way of highlighting the complex interactions of variables such as comorbid conditions and medications on MP concentrations. © 2020 The Authors.
Rights/Terms© 2020 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/13546
- Type 2 diabetes and older age contribute to elevated plasma microparticle concentrations independent of chronic stroke.
- Authors: Landers-Ramos RQ, Serra MC, Blumenthal JB, Ryan AS, Hafer-Macko CE, Prior SJ
- Issue date: 2018 Nov
- Circulating endothelial microparticles and <i>miR-92a</i> in acute myocardial infarction.
- Authors: Zhang Y, Cheng J, Chen F, Wu C, Zhang J, Ren X, Pan Y, Nie B, Li Q, Li Y
- Issue date: 2017 Apr 28
- Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction.
- Authors: Marei I, Chidiac O, Thomas B, Pasquier J, Dargham S, Robay A, Vakayil M, Jameesh M, Triggle C, Rafii A, Jayyousi A, Al Suwaidi J, Abi Khalil C
- Issue date: 2022 Feb 2
- Circulating CD62E+ microparticles and cardiovascular outcomes.
- Authors: Lee ST, Chu K, Jung KH, Kim JM, Moon HJ, Bahn JJ, Im WS, Sunwoo J, Moon J, Kim M, Lee SK, Roh JK
- Issue date: 2012
- Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.
- Authors: Li B, Huang Q, Lin C, Lu R, Wang T, Chen X, Liu Z, Liu Y, Wu J, Wu Y, Liao S, Ding X
- Issue date: 2021 Jan 15